12 Health Care Stocks Moving In Thursday's Pre-Market Session

Bluejay Diagnostics, Inc. -5.14% Pre
CINGULATE INC. -15.33% Pre
CRINETICS PHARMACEUTICALS, INC. -2.04% Pre
CytoSorbents Corporation -0.60% Pre
Enveric Biosciences Inc Ordinary Shares -8.76% Pre

Bluejay Diagnostics, Inc.

BJDX

0.59

0.59

-5.14%

0.00% Pre

CINGULATE INC.

CING

0.78

0.78

-15.33%

0.00% Pre

CRINETICS PHARMACEUTICALS, INC.

CRNX

43.68

43.68

-2.04%

0.00% Pre

CytoSorbents Corporation

CTSO

0.87

0.87

-0.60%

0.00% Pre

Enveric Biosciences Inc Ordinary Shares

ENVB

0.92

0.89

-8.76%

-3.64% Pre

Gainers

  • Cingulate (NASDAQ:CING) stock moved upwards by 188.5% to $11.51 during Thursday's pre-market session. The market value of their outstanding shares is at $10.7 million.
  • SenesTech (NASDAQ:SNES) shares rose 82.02% to $1.57. The company's market cap stands at $1.1 million.
  • Palisade Bio (NASDAQ:PALI) shares moved upwards by 55.83% to $0.94. The market value of their outstanding shares is at $8.6 million.
  • Milestone Scientific (AMEX:MLSS) stock moved upwards by 26.72% to $0.8. The company's market cap stands at $60.5 million.
  • Enveric Biosciences (NASDAQ:ENVB) stock increased by 26.67% to $1.65. The market value of their outstanding shares is at $3.8 million.
  • Telesis Bio (NASDAQ:TBIO) stock rose 23.93% to $0.48. The market value of their outstanding shares is at $14.4 million.

Losers

  • Bluejay Diagnostics (NASDAQ:BJDX) stock fell 34.5% to $1.15 during Thursday's pre-market session. The company's market cap stands at $1.4 million.
  • CytoSorbents (NASDAQ:CTSO) shares fell 32.52% to $1.1. The market value of their outstanding shares is at $57.3 million.
  • First Wave BioPharma (NASDAQ:FWBI) stock declined by 15.74% to $4.66. The market value of their outstanding shares is at $3.1 million.
  • NKGen Biotech (NASDAQ:NKGN) stock declined by 12.05% to $2.92. The company's market cap stands at $63.9 million.
  • Intensity Therapeutics (NASDAQ:INTS) shares declined by 10.59% to $6.0. The company's market cap stands at $82.2 million.
  • Crinetics Pharmaceuticals (NASDAQ:CRNX) shares decreased by 9.98% to $32.75. The company's market cap stands at $2.1 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via